GEN-MKT-18-7897-A
Mar 18, 2026 | Biopharma, Blogs, Clinical, Environmental / Industrial, Food / Beverage, Forensic, Life Science Research, Pharma, Service, Support, Technology | 0 comments
Read time: 4 minutes
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Yet many laboratories still manage service reactively, addressing issues only when they occur through Time and Material (T&M) support. While T&M can feel flexible in the short term, over time, it often introduces unpredictability that laboratories cannot afford.
That is why more organizations are re-evaluating their service strategy and transitioning to fixed-price service plans. Not simply as a cost decision, but to protect uptime, stabilize budgets, and support long‑term performance.
The hidden cost of reactive service
A repair invoice is visible. Operational disruption is not.
When a mass spectrometer goes down, the impact often extends well beyond the service event itself:
In regulated environments, even short interruptions can create audit risk and long‑lasting operational consequences.
Over time, just two emergency service visits can approach, or even exceed, the cost of annual service coverage. This comparison does not account for planned maintenance that goes unperformed or the additional downtime incurred while waiting for a purchase order to be approved.
Data shows that systems without a service contract can expect case resolution times twice as long as those for covered systems. Response prioritization and the absence of routine maintenance and administrative delays are factors contributing to these extended resolution times.
And more importantly, reactive service introduces volatility into both budgets and performance planning.
Use the Uptime Mastery calculator to estimate the potential cost of unexpected downtime in your lab.
Why stability drives scientific confidence
Fixed-price service plans are designed to reduce uncertainty across three critical areas:
1. Operational uptime
Preventive maintenance and proactive system care help maintain instrument robustness, sensitivity, and reproducibility. Addressing potential issues before failure reduces unplanned downtime and protects workflow continuity.
For high-throughput environments, this stability enables predictable turnaround times and reliable reporting.
2. Budget predictability
Unplanned repairs introduce variability that can strain operational budgets. Fixed-price service shifts variable repair costs into a predictable annual investment.
This makes financial planning more transparent and reduces the need for emergency reallocation of the budget, particularly in grant-funded or cost-controlled environments.
3. Compliance and documentation support
In GMP, GLP, and ISO-regulated laboratories, documentation matters.
Scheduled maintenance records, traceable OEM parts, and structured service documentation support audit readiness and help demonstrate consistent oversight.
A proactive service model aligns more naturally with compliance-driven workflows.
Protecting instrument performance over time
Mass spectrometry systems are precision instruments. Sensitivity, mass accuracy, and reproducibility depend on proper maintenance and system optimization. A regularly serviced mass spectrometer system will achieve up to 18% higher productivity than a system without a service plan.
Without regular service, even minor performance deviations can accumulate, leading to:
Proactive service helps preserve instrument health, extend system performance, and protect your analytical investment over its full lifecycle.
Supporting throughput in revenue-generating labs
For CROs and clinical laboratories, uptime directly affects revenue and client trust. Each unexpected day offline can mean:
Feedback has shown that an average CRO would lose around $10 per minute, or $600 per hour, when an instrument goes down unexpectedly, which can soon add up to $1000s.
A structured service plan helps reduce recovery time and supports faster response, minimizing disruption to revenue-generating operations.
Long-term value vs. short-term flexibility
Time and Material service can be appropriate
when events are infrequent. But as instruments age or utilization increases, reactive service can become progressively less predictable, both operationally and financially.
SCIEX LC-MS and CE service and support plans offer:
Over multiple years, the combination of reduced downtime, fewer emergency events, and predictable budgeting often delivers measurable operational value.
A strategic approach to service
Choosing a service model is not just a purchasing decision; it is an operational strategy.
Laboratories increasingly view service plans as part of their broader risk management approach, helping to:
In high-performance analytical environments, service is not simply about fixing problems. It is about preventing them.
Watch this webinar with Andy Wilcox, Senior Market Development Manager – Aftermarket and Software, SCIEX, to learn how you can unlock the value of a SCIEX service contract.
From reactive to reliable
Mass spectrometry supports critical decisions, from drug development to clinical diagnostics and environmental safety. Pairing that performance with a proactive service strategy helps ensure your systems deliver the reliability your science depends on. Predictable service supports predictable results.
Consult with a service and support expert and find a service plan that best fits your operational needs.
Bonus tip: Reviewing service events and downtime over the past 12 months often provides a clear picture of which service model best supports your lab’s long‑term goals.
As an analytical strategy, middle-down mass spectrometry (MS) workflows characterize biotherapeutic proteins by analyzing large, digested protein fragments or defined subunits, rather than fully intact proteins (top-down) or digested peptides (bottom-up). A middle-down strategy combines the strengths of top-down and bottom-up approaches by delivering high sequence coverage and structural specificity while maintaining relatively simple sample preparation. In practice, middle-down analysis enables accurate mass measurement, rapid sequence confirmation, and localization of key post-translational modifications (PTMs) on protein subunits that are directly relevant to product quality.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
Posted by
You must be logged in to post a comment.
Share this post with your network